Drugs in R & D

, Volume 2, Issue 4, pp 249–250 | Cite as

MK 869

L 754030, MK 0869
Section 1: Antiemetics in Oncology Adis R&D Profile


Adis International Limited Paroxetine Sexual Dysfunction Granisetron Single Oral 400mg Dose 


  1. 1.
    Elwood W. Dawn of a new era with substance P antagonists in depression? Inpharma 1998 Sep 12; 1154: 9–10Google Scholar
  2. 2.
    Feighner JP. Substance P. Eur Neuropsychopharmacol 1998 Nov; 8 Suppl. 2: 85CrossRefGoogle Scholar
  3. 3.
    Tattersall FD, Rycroft W, Hale JJ, et al. The NK1 receptor antagonist L-754,030 and its N-phosphoryl prodrug L-758,298 inhibit acute and delayed cisplatin-induced emesis in the ferret. 34th Annual Meeting of the American Society of Clinical Oncology; 1998 May 16–19; Los Angeles, 253Google Scholar
  4. 4.
    Navari RM, Reinhardt RR, Gralla RJ, L-754,030 Antiemetic Trials Group, et al. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. N Engl J Med 1999 21 Jan; 340: 190–5PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations